Paul J. Mellett
2014
In 2014, Paul J. Mellett earned a total compensation of $1.3M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
Bonus | $117,891 |
---|---|
Option Awards | $877,954 |
Salary | $322,408 |
Other | $11,369 |
Total | $1,329,622 |
Mellett received $878K in option awards, accounting for 66% of the total pay in 2014.
Mellett also received $117.9K in bonus, $322.4K in salary and $11.4K in other compensation.
Rankings
In 2014, Paul J. Mellett's compensation ranked 6,307th out of 13,032 executives tracked by ExecPay. In other words, Mellett earned more than 51.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,307 | 52nd |
Manufacturing | 2,296 | 54th |
Chemicals And Allied Products | 771 | 54th |
Drugs | 604 | 56th |
Pharmaceutical Preparations | 461 | 56th |
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2014.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019